HAZZAN M. Daclizumab versus thymoglobulin in renal transplant recipients with a high immunological risk: a prospective French-Belgian randomized trial. 119. GHISDAL L, LEBRANCHU Y, ALAMARTINE E, LE MEUR Y, TOUCHARD G, NOËL C, ESSIG M, MERVILLE P, AZARCHOUCH Z, <strong>ABRAMOWICZ</strong> M, <strong>ABRAMOWICZ</strong> D. A missense mutation in proteasome B5 subunit is significantly associated with acute rejection in non-immunized renal transplant patients. Belgian Transplantation Society, Brussels, March 2011 120. BRACONNIER P, DELMARMOL V, BROEDERS N, KIANDA M, MASSART A, LEMY A, GHISDAL L, LEMOINE A, MADHOUN P, RACAPÉ J, <strong>ABRAMOWICZ</strong> D, WISSING KM. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tracrolimus: effect on malignancies in a single centre retrospective cohort study of 929 renal transplant recipients. Belgian Transplantation Society, Brussels, March 2011 121. LEMY A, ANDRIEN M, LIONET A, LABALETTE M, NOEL C, HIESSE C, DELAHOUSSE M, SUBERBIELLE C, DEMEYER M, LATINNE D, MOURAD M, RACAPÉ J, WISSING KM, TOUNGOUZ M, <strong>ABRAMOWICZ</strong> D. Impact of post-transplant MICA antibodies on long-term graft outcomes: a multicenter analysis of 788 renal transplant patients. Belgian Transplantation Society, Brussels, March 2011 122. Ghisdal L, Coppieters W, Lebranchu Y, Alamartine E, Le Meur Y, Touchard G, Glowacki F, Essig M, Merville P, Ajarchouh Z, Dinic M, Massart A, Georges M, Abramowicz M, Abramowicz D. Genome-wide association study identifies 13 loci associated with acute T-cell rejection in caucasian renal transplant patients. 123. Kianda M, Wissing KM, Maddhoun P, Hougardy JM, Broeders N, Massart A, Benahmed A, Vereerstraeten P, Hoang AD, Racapé J, Abramowicz D. Does loss 76
to follow-up affects outcomes of renal transplantation ? A retrospective study of 849 patients. 77
- Page 1 and 2:
CURRICULUM VITAE - DANIEL ABRAMOWIC
- Page 3 and 4:
� Membre du Conseil d'Administrat
- Page 5 and 6:
� Directeur de la thèse de docto
- Page 7 and 8:
Articles originaux publiés dans de
- Page 9 and 10:
mice. European Journal of Immunolog
- Page 11 and 12:
29. HUYGEN K, ABRAMOWICZ D, VANDENB
- Page 13 and 14:
43. MARCHANT A, BRUYNS C, VANDENABE
- Page 15 and 16:
57. VANHERWEGHEM JL, ABRAMOWICZ D,
- Page 17 and 18:
71. BROEDERS N, WISSING KM, CRUSIAU
- Page 19 and 20:
86. M. JADOUL, C. DODÉ, J.P. COSYN
- Page 21 and 22:
DIRESKENELI, M. GALEAZZI, A. GÜL,
- Page 23 and 24:
108. BROEDERS N, WISSING M, HAZZAN
- Page 25 and 26: guidelines: a European Renal Best P
- Page 27 and 28: ABRAMOWICZ D. Major Histocompatibil
- Page 29 and 30: 142. BRACONNIER P, DEL MARMOL V, BR
- Page 31 and 32: ABRAMOWICZ D Kidney graft dysfuncti
- Page 33 and 34: 7. VEREERSTRAETEN P, ANDRIEN M, DE
- Page 35 and 36: VANHERWEGHEM JL, VEREERSTRAETEN P O
- Page 37 and 38: Chapitres de livres 1. ABRAMOWICZ D
- Page 39 and 40: Abstracts présentés lors de congr
- Page 41 and 42: Renal Association, Göteborg, juin
- Page 43 and 44: 29. VEREERSTRAETEN P, ANDRIEN M, DE
- Page 45 and 46: TH2 helper cells escape anti-CD3-me
- Page 47 and 48: Médicale, Décembre 1992. 56. PRAD
- Page 49 and 50: Sixth Congress of the European Soci
- Page 51 and 52: might mitigate OKT3 toxicity. 27th
- Page 53 and 54: VANDERHAEGEN, F. BULTE, M. GOLDMAN,
- Page 55 and 56: World Congress of Nephrology, San F
- Page 57 and 58: 128. M WISSING, I DUPONT, P UNGER,
- Page 59 and 60: Octobre 2006. 141. BROEDERS N, HAZZ
- Page 61 and 62: 8. ABRAMOWICZ D, VANDERVORST P, LAM
- Page 63 and 64: GOLDMAN M La tolérance néonatale
- Page 65 and 66: 38. ABRAMOWICZ D Immunothérapie et
- Page 67 and 68: La transplantation rénale expose-t
- Page 69 and 70: Belge de transplantation, Bruxelles
- Page 71 and 72: 2 ème Congrès Francophone de Rech
- Page 73 and 74: 97. F. SCHUIND, C VAN HOLDER, D ABR
- Page 75: Laparoscopic kidney procurement for
- Page 79 and 80: 13. ABRAMOWICZ D Le rôle des lymph
- Page 81 and 82: Orateur invité au Deuxième congr
- Page 83 and 84: 67. ABRAMOWICZ D HLA in renal Trans
- Page 85: 88. ABRAMOWICZ D Impact clinique de
Change language